Cite
HARVARD Citation
Pavord, I. et al. (2022). From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases. Allergy. 77 (3), pp. 778-797. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pavord, I. et al. (2022). From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases. Allergy. 77 (3), pp. 778-797. [Online].